Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
Status:
Terminated
Trial end date:
2016-08-31
Target enrollment:
Participant gender:
Summary
This is an open-label comparative study in three parallel groups. It is expected that 90
patients and/or healthy volunteers will participate in this biomedical research.
Distribution in groups
- 30 patients with type 2 diabetes and an indication for treatment with a GLP1 analogue
(group 1)
- 30 patients with type 2 diabetes (control diabetic subjects) not treated with Incretins
(group 2)
- 30 healthy subjects (non-diabetics) (group 3)
This study will investigate modifications in eating behaviour induced by Liraglutide in
patients who start treatment with Victoza® and certain aspects, such as liking (hedonic
characteristic of a food), wanting (desire to eat a given food) and salivation in response to
the presentation of a food by taking measurements at D0 (before initiation of the treatment
with Liraglutide in the group concerned) then at 15 days (except for the controls), 3 months
and 9 months (only for controls).